Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - April 2008

  1. Immunization Information Systems Progress--United States, 2006.   MMWR Morb Mortal Wkly Rep; 57 (11): 289-291; March 21, 2008.

  2. U.S.-Incurred Costs of Wild Poliovirus Infections in a Camp With U.S.-Bound Refugees--Kenya, 2006.   MMWR Morb Mortal Wkly Rep; 57 (9): 232-235; March 7, 2008.

  3. Cost of Vaccinating Refugees Overseas Versus After Arrival in the United States, 2005.   MMWR Morb Mortal Wkly Rep; 57 (9): 229-232; March 7, 2008.

  4. Fifteen Infectious Diseases Have Been Enrolled in the National Immunization Drive.   Chin Med J (Engl ); 121 (6): 565; March, 2008.

  5. Abramson, J. S.; Almquist, J. R.; Jenkins, R. R.; Bocchini, J. A., Jr.; Davis, R. M.; Langston, E. L.; Hale, R. W.; Gall, S. A.  Prioritisation of Routine Vaccines: a Mistake for the USA.   Lancet; 371 (9616): 881-882; March 15, 2008.

  6. Adamkiewicz, T. V.; Silk, B. J.; Howgate, J.; Baughman, W.; Strayhorn, G.; Sullivan, K.; Farley, M. M.  Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life.   Pediatrics; 121 (3): 562-569; March, 2008.

  7. Andrus, J. K.; Crouch, A. A.; Fitzsimmons, J.; Vicari, A.; Tambini, G.  Immunization and the Millennium Development Goals: Progress and Challenges in Latin America and the Caribbean.   Health Aff (Millwood ); 27 (2): 487-493; March, 2008.

  8. Aremi-Williams, R. I.; Igwilo, C. I.  Community Pharmacies As Possible Centres for Routine Immunization.   Nig Q J Hosp Med; 17 (4): 131-133; October, 2007.

  9. Atrasheuskaya, A. V.; Kulak, M. V.; Neverov, A. A.; Rubin, S.; Ignatyev, G. M.  Measles Cases in Highly Vaccinated Population of Novosibirsk, Russia, 2000-2005.   Vaccine; February 27, 2008.  [Epub ahead of print].

  10. Bair, R. M.; Mays, R. M.; Sturm, L. A.; Perkins, S. M.; Juliar, B. E.; Zimet, G. D.  Acceptability to Latino Parents of Sexually Transmitted Infection Vaccination.   Ambul Pediatr; 8 (2): 98-103; March 17, 2008.

  11. Brauchli, Y. B.; Gittermann, M.; Michot, M.; Krahenbuhl, S.; Gnehm, H. E.  A FATAL TICK BITE OCCURRING DURING THE COURSE OF TICK-BORNE ENCEPHALITIS VACCINATION.   Pediatr Infect Dis J; 27(4):363-365. April, 2008.

  12. Braun, M. M.  Toward Better Vaccine Safety Data and Safer Vaccination.   Pediatrics; 121 (3): 625-626; March, 2008. VAERS

  13. Chapman, L. E.; Iskander, J. K.; Chen, R. T.; Neff, J.; Birkhead, G. S.; Poland, G.; Gray, G. C.; Siegel, J.; Sepkowitz, K.; Robertson, R. M.; Yancy, C.; Guerra, F. A.; Gardner, P.; Modlin, J. F.; Maurer, T.; Berger, T.; Flanders, W. D.; Shope, R.  A Process for Sentinel Case Review to Assess Causal Relationships Between Smallpox Vaccination and Adverse Outcomes, 2003-2004.   Clin Infect Dis; 46 (Suppl 3): S271-S293; March 15, 2008. VAERS

  14. Chapman, L. E.; Mootrey, G. T.; Neff, L. J.  Introduction: Vaccination Against Smallpox in the Posteradication Era.   Clin Infect Dis; 46 (Suppl 3): S153-S156; March 15, 2008.

  15. Chudasama, R. K.  Evaluation of Intensive Pulse Polio Immunization in District Valsad During 2007.   Indian Pediatr; 45 (3): 233-235; March 7, 2008.

  16. Clements, C. J.; Nshimirimanda, D.; Gasasira, A.  Using Immunization Delivery Strategies to Accelerate Progress in Africa Towards Achieving the Millennium Development Goals.   Vaccine; 26 (16): 1926-1933; April 7, 2008.

  17. Colombo, G. L.; Ferro, A.; Vinci, M.; Zordan, M.; Serra, G.  Cost-Benefit Analysis of Influenza Vaccination in a Public Healthcare Unit.   Ther Clin Risk Manag; 2 (2): 219-226; June, 2006.

  18. Constenla, D.; Ortega-Barria, E.; Rheingans, R. D.; Antil, L.; Saez-Llorens, X.  [Economic Impact of Rotavirus Vaccination in Panama.].   An Pediatr (Barc ); 68 (2): 128-135; February, 2008.

  19. Cortese, M. M.; Baughman, A. L.; Zhang, R.; Srivastava, P. U.; Wallace, G. S.  Pertussis Hospitalizations Among Infants in the United States, 1993 to 2004.   Pediatrics; 121 (3): 484-492; March, 2008.

  20. Del Rio Camacho, G.; Perea-Milla Lopez, E.; Romero Gonzalez, J.; Gonzalez Canoniga, A.; Munumel Alameda, B.; Martin Cabello, O.; Martinez Collado, M.; Perez Frias, J.  Prevalence of Tuberculosis Infection in BCG-Vaccinated and Unvaccinated Mediterranean Schoolchildren.   Arch Bronconeumol; 44 (2): 75-80; February, 2008.

  21. Dibonaventura, M. D.; Chapman, G. B.  Do Decision Biases Predict Bad Decisions? Omission Bias, Naturalness Bias, and Influenza Vaccination.   Med Decis Making; March 4, 2008. [Epub ahead of print].

  22. Duintjer Tebbens, R. J.; Thompson, K. M.; Hunink, M. G.; Mazzuchi, T. A.; Lewandowski, D.; Kurowicka, D.; Cooke, R. M.  Uncertainty and Sensitivity Analyses of a Dynamic Economic Evaluation Model for Vaccination Programs.   Med Decis Making; 28 (2): 182-200; March, 2008.

  23. France, E. K.; Glanz, J.; Xu, S.; Hambidge, S.; Yamasaki, K.; Black, S. B.; Marcy, M.; Mullooly, J. P.; Jackson, L. A.; Nordin, J.; Belongia, E. A.; Hohman, K.; Chen, R. T.; Davis, R.  Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in Children.   Pediatrics; 121 (3): e687-e692; March, 2008.

  24. Francis, P. T.  Maternal Vaccination Against Pertussis.   Lancet Infect Dis; 8 (4): 214; April, 2008.

  25. Gai, W.; Zou, W.; Lei, L.; Luo, J.; Tu, H.; Zhang, Y.; Wang, K.; Tien, P.; Yan, H.  Effects of Different Immunization Protocols and Adjuvant on Antibody Responses to Inactivated SARS-CoV Vaccine.   Viral Immunol; 21 (1): 27-37; March, 2008.

  26. Gao, S.; Teng, Z.; Nieto, J. J.; Torres, A.  Analysis of an SIR Epidemic Model With Pulse Vaccination and Distributed Time Delay.   J Biomed Biotechnol; 2007: 64870; 2007.

  27. Grgic-Vitek, M.; Klavs, I.; Kraigher, A.  Re-Emergence of Pertussis in Slovenia: Time to Change Immunization Policy.   Vaccine; 26 (15): 1874-1878; March 28, 2008.

  28. Hampton, T.  Research Reveals Low Immunization Rates and Vaccination Awareness Among Adults.   JAMA; 299 (9): 1007; March 5, 2008.

  29. Havli, J.  [The Importance of Pneumococcal Vaccination - a Clinician's View.].   Klin Mikrobiol Infekc Lek; 14 (1): 30-35; February, 2008.

  30. Hayanga, A. J.; Kaiser, H. E.  Medical Information on YouTube.   JAMA; 299 (12): 1424-1425; March 26, 2008.

  31. Hoshi, S. L.; Kondo, M.; Okubo, I.  [Study on Pricing and Uptake Rate of Influenza Vaccination for the Elderly in Japan With a Simple Random Sampling Method].   Nippon Koshu Eisei Zasshi; 55 (1): 19-29; January, 2008.

  32. Jackson, L. A.; Starkovich, P.; Dunstan, M.; Yu, O.; Nelson, J.; Dunn, J.; Rees, T.; Zavitkovsky, A.; Maus, D.; Froeschle, J. E.; Decker, M.  Prospective Assessment of the Effect of Needle Length and Injection Site on the Risk of Local Reactions to the Fifth Diphtheria-Tetanus-Acellular Pertussis Vaccination.   Pediatrics; 121 (3): e646-e652; March, 2008.

  33. Kahng, J.; Lee, H. J.  [Clinical Efficacy of HPV DNA Chip Test in the Era of HPV Vaccination: 1,211 Cases, A Single Institution Study.].   Korean J Lab Med; 28 (1): 70-78; February, 2008.

  34. Kalies, H.; Redel, R.; Varga, R.; Tauscher, M.; von, Kries R.  Vaccination Coverage in Children Can Be Estimated From Health Insurance Data.   BMC Public Health; 8: 82; March 1, 2008.

  35. Kasten, M. J.; Poland, G. A.  Influenza Vaccination and the Elderly : Pandemic Preparedness.   Drugs Aging; 25 (3): 179-186; 2008.

  36. Keshtkar-Jahromi, M.; Argani, H.; Rahnavardi, M.; Mirchi, E.; Atabak, S.; Tara, S. A.; Gachkar, L.; Noori-Froothghe, A.; Mokhtari-Azad, T.  Antibody Response to Influenza Immunization in Kidney Transplant Recipients Receiving Either Azathioprine or Mycophenolate: A Controlled Trial.   Am J Nephrol; 28 (4): 654-660; March 6, 2008.

  37. Khan, M. M.  Economics of Polio Vaccination in the Post-Eradication Era: Should OPV-Using Countries Adopt IPV?   Vaccine; 26 (16): 2034-2040; April 7, 2008.

  38. Klein, N. P.; Massolo, M. L.; Greene, J.; Dekker, C. L.; Black, S.; Escobar, G. J.  Risk Factors for Developing Apnea After Immunization in the Neonatal Intensive Care Unit.   Pediatrics; 121 (3): 463-469; March, 2008.

  39. Kroger, A.; Vellozzi, C.; Deming, M.; Casey, C. G.; Wen, X.; Norton, S. A.  Dermatological Lesions Near the Smallpox Vaccination Site After Scab Detachment.   Clin Infect Dis; 46 (Suppl 3): S227-S233; March 15, 2008.

  40. Kumar, D.; Manuel, O.; Humar, A.  Response to: Larger Dose of Intradermal Influenza Vaccination May Be More Immunogenic in Transplant Recipients.   Am J Transplant; 2008 Feb 29 [Epub ahead of print].

  41. Laguna, C.; Martinez, L.; Sanchez, J. L.; Alegre, V.  Squamous Cell Carcinoma at Tetanus Vaccination Site.   J Eur Acad Dermatol Venereol; 2008 Mar 7 [Epub ahead of print].

  42. Lahdenpera, A. I.; Nilsson, L. J.; Regnstrom, K.  Kinetics of Asthma- and Allergy-Associated Immune Response Gene Expression in Peripheral Blood Mononuclear Cells From Vaccinated Infants After in Vitro Re-Stimulation With Vaccine Antigen.   Vaccine; 26 (14): 1725-1730; March 25, 2008.

  43. Lennon, D.  The Role of MeNZB Vaccination in Controlling the New Zealand Meningococcal Epidemic.   N Z Med J; 121 (1270): 110-112; March 14, 2008.

  44. Lin, M. Y.; Ottenhoff, T. H.  Not to Wake a Sleeping Giant: New Insights into Host-Pathogen Interactions Identify New Targets for Vaccination Against Latent Mycobacterium Tuberculosis Infection.   Biol Chem; March 6, 2008. [Epub ahead of print].

  45. Lippman, A.; Boscoe, M.; Scurfield, C.  Rebuttal: Do You Approve of Spending $300 Million on HPV Vaccination? No.   Can Fam Physician; 54 (3): 343, 345; March, 2008.

  46. Lu, P.; Bridges, C. B.; Euler, G. L.; Singleton, J. A.  Influenza Vaccination of Recommended Adult Populations, U.S., 1989-2005.   Vaccine; 26 (14): 1786-1793; March 25, 2008.

  47. Luman, E. T.; Sablan, M.; Stokley, S.; McCauley, M. M.; Shaw, K. M.  Impact of Methodological 'Shortcuts' in Conducting Public Health Surveys: Results From a Vaccination Coverage Survey.   BMC Public Health; 8 (1): 99; March 27, 2008.

  48. Mahmoud, A.; Levin, M.  Vaccines at the Turn of the 21st Century: a New Era for Immunization in Public Health.   Int J Infect Dis; 11 (Suppl 2): S1-S2; November, 2007.

  49. Maltezou, H. C.; Maragos, A.; Katerelos, P.; Paisi, A.; Karageorgou, K.; Papadimitriou, T.; Pierroutsakos, I. N.  Influenza Vaccination Acceptance Among Health-Care Workers: A Nationwide Survey.   Vaccine; 26 (11): 1408-1410; March 10, 2008.

  50. Mangrio, N. K.; Alam, M. M.; Shaikh, B. T.   Is Expanded Programme on Immunization Doing Enough? Viewpoint of Health Workers and Managers in Sindh, Pakistan.   J Pak Med Assoc; 58 (2): 64-67; February, 2008.

  51. Mathew, J. L.  Universal Pneumococcal Vaccination for India.   Indian Pediatr; 45 (2): 160-161; February, 2008.

  52. Mishra, A.; Mishra, R.  Universal Pneumococcal Vaccination in India: Is It a Priority?   Indian Pediatr; 45 (2): 161-162; February, 2008.

  53. Mooi, F. R.; de Greeff, S. C.  Maternal Vaccination Against Pertussis - Authors' Reply.   Lancet Infect Dis; 8 (4): 214-215; April, 2008.

  54. Morgan, J.; Roper, M. H.; Sperling, L.; Schieber, R. A.; Heffelfinger, J. D.; Casey, C. G.; Miller, J. W.; Santibanez, S.; Herwaldt, B.; Hightower, P.; Moro, P. L.; Hibbs, B. F.; Levine, N. H.; Chapman, L. E.; Iskander, J.; Lane, J. M.; Wharton, M.; Mootrey, G. T.; Swerdlow, D. L.  Myocarditis, Pericarditis, and Dilated Cardiomyopathy After Smallpox Vaccination Among Civilians in the United States, January-October 2003.   Clin Infect Dis; 46 (Suppl 3): S242-S250; March 15, 2008. VAERS

  55. Mossad, S. B.  Larger Dose of Intradermal Influenza Vaccination May Be More Immunogenic in Transplant Recipients.   Am J Transplant; 2008 March 2 [Epub ahead of print].

  56. Nakajima, H.; Kariya, H.; Ohata, R.; Ogura, H.  Investigation of Immunity Level Against Diphtheria and Reinforcement of Immunity by Booster Vaccination for Infection Control Staff in Okayama Prefecture.   Jpn J Infect Dis; 61 (2): 104-106; March, 2008.

  57. Neff, J.; Modlin, J.; Birkhead, G. S.; Poland, G.; Robertson, R. M.; Sepkowitz, K.; Yancy, C.; Gardner, P.; Gray, G. C.; Maurer, T.; Siegel, J.; Guerra, F. A.; Berger, T.; Flanders, W. D.; Shope, R.  Monitoring the Safety of a Smallpox Vaccination Program in the United States: Report of the Joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board.   Clin Infect Dis; 46 (Suppl 3): S258-S270; March 15, 2008.

  58. Newall, A. T.; Scuffham, P. A.; Kelly, H.; Harsley, S.; Macintyre, C. R.  The Cost-Effectiveness of a Universal Influenza Vaccination Program for Adults Aged 50-64 Years in Australia.   Vaccine; 26(17): 2142-2153; February, 2008.

  59. Ochoa-Gondar, O.; Vila-Corcoles, A.; Ansa, X.; Rodriguez-Blanco, T.; Salsench, E.; de, Diego C.; Raga, X.; Gomez, F.; Valdivieso, E.; Fuentes, C.; Palacios, L.  Effectiveness of Pneumococcal Vaccination in Older Adults With Chronic Respiratory Diseases: Results of the EVAN-65 Study.   Vaccine; 26 (16): 1955-1962; April 7, 2008.

  60. Ortega-Sanchez, I. R.; Sniadack, M. M.; Mootrey, G. T.  Economics of Cardiac Adverse Events After Smallpox Vaccination: Lessons From the 2003 US Vaccination Program.   Clin Infect Dis; 46 (Suppl 3): S168-S178; March 15, 2008.

  61. Parikh, R. K.  Fighting for the Reputation of Vaccines: Lessons From American Politics.   Pediatrics; 121 (3): 621-622; March, 2008. 

  62. Rashid, H.; Shafi, S.; Haworth, E.; Booy, R.  Pneumococcal Vaccination in Adults.   Arch Intern Med; 168 (6): 666-667; March 24, 2008.

  63. Rendi-Wagner, P.; Paulke-Korinek, M.; Kundi, M.; Wiedermann, U.; Laaber, B.; Kollaritsch, H.  Seroprotection 4 Years Following Booster Vaccination Against Tick-Borne Encephalitis.   Int J Med Microbiol; March 5, 2008. [Epub ahead of print].

  64. Riddle, M. S.; Patel, S. S.; Sanders, J. W.; Armstrong, A. W.; Putnam, S. D.; Schlett, C. D.; Tribble, D. R.  Attitudes Toward Predeployment and Experimental Vaccinations Among Troops Deployed to Operation Iraqi Freedom and Operation Enduring Freedom.   J Travel Med; 15 (2): 68-76; March, 2008.

  65. Romanowska, M.; Rybicka, K.; Nowak, I.; Jozefczuk, J.; Zycinska, K.; Radzikowski, A.; Brydak, L. B.  Antibody Response to Influenza Vaccination in Patients Suffering From Asthma.   J Physiol Pharmacol; 58 (Suppl 5-Pt2): 583-589; November, 2007.

  66. Ruiz-Rodriguez, M.; Vera-Cala, L. M.; Lopez-Barbosa, N.  [Health Insurance for Infants and Infant Vaccination Related to Forced-Displacement in Colombia.].   Rev Salud Publica (Bogota ); 10 (1): 49-61; January, 2008.

  67. Samuelsson, O.; Herlitz, H.  Vaccination Against High Blood Pressure: a New Strategy.   Lancet; 371 (9615): 788-789; March 8, 2008.

  68. Senior, K.  Global Aspirations for HPV Vaccination.   Lancet Infect Dis; 8 (3): 150; March, 2008.

  69. Smith, P. J.; Stevenson, J.  Racial/Ethnic Disparities in Vaccination Coverage by 19 Months of Age: An Evaluation of the Impact of Missing Data Resulting From Record Scattering.   Stat Med; March 14, 2008. [Epub ahead of print].

  70. Sniadack, M. M.; Neff, L. J.; Swerdlow, D. L.; Schieber, R. A.; McCauley, M. M.; Mootrey, G. T.  Follow-Up of Cardiovascular Adverse Events After Smallpox Vaccination Among Civilians in the United States, 2003.   Clin Infect Dis; 46 (Suppl 3): S251-S257; March 15, 2008.

  71. Steben, M.  Rebuttal: Do You Approve of Spending $300 Million on HPV Vaccination? Yes.   Can Fam Physician; 54 (3): 342, 344; March, 2008.

  72. Suraratdecha, C.; Ramana, C. V.; Kaipilyawar, S.; Krishnamurthy; Sivalenka, S.; Ambatipudi, N.; Gandhi, S.; Umashankar, K.; Cheyne, J.  Cost and Effectiveness Analysis of Immunization Service Delivery Support in Andhra Pradesh, India.   Bull World Health Organ; 86 (3): 221-228; March, 2008.

  73. Swerdlow, D. L.; Roper, M. H.; Morgan, J.; Schieber, R. A.; Sperling, L. S.; Sniadack, M. M.; Neff, L.; Miller, J. W.; Curtis, C. R.; Marin, M. E.; Iskander, J.; Moro, P.; Hightower, P.; Levine, N. H.; McCauley, M.; Heffelfinger, J.; Damon, I.; Torok, T. J.; Wharton, M.; Mast, E. E.; Mootrey, G. T.  Ischemic Cardiac Events During the Department of Health and Human Services Smallpox Vaccination Program, 2003.   Clin Infect Dis; 46 (Suppl 3); March 15, 2008.

  74. Tjelle, T. E.; Rabussay, D.; Ottensmeier, C.; Mathiesen, I.; Kjeken, R.  Taking Electroporation-Based Delivery of DNA Vaccination into Humans: a Generic Clinical Protocol.   Methods Mol Biol; 423: 497-507; 2008.

  75. Uskun, E.; Uskun, S. B.; Uysalgenc, M.; Yagiz, M.  Effectiveness of a Training Intervention on Immunization to Increase Knowledge of Primary Healthcare Workers and Vaccination Coverage Rates.   Public Health; February 28, 2008. [Epub ahead of print].

  76. Vandelaer, J.; Bilous, J.; Nshimirimana, D.  Reaching Every District (RED) Approach: a Way to Improve Immunization Performance.   Bull World Health Organ; 86 (3): A-B; March, 2008.

  77. Wiesik-Szewczyk, E.; Lacki, J. K.; Chwaliniska-Sadowska, H.  [Should We Vaccinate Patients With Systemic Lupus].    Pol Merkur Lekarski; 23 (137): 395-398; November, 2007.

  78. Wilder-Smith, A.; Hill, D. R.; Freedman, D. O.  The Revised International Health Regulations (2005): Impact on Yellow Fever Vaccination in Clinical Practice.   Am J Trop Med Hyg; 78 (3): 359-360; March, 2008.

  79. Woodland, D. L.  Vaccination Strategies.   Viral Immunol; 21 (1): 1-2; March, 2008.